4.84
price up icon5.91%   0.27
after-market Dopo l'orario di chiusura: 4.81 -0.03 -0.62%
loading
Precedente Chiudi:
$4.57
Aprire:
$4.52
Volume 24 ore:
1.09M
Relative Volume:
1.12
Capitalizzazione di mercato:
$147.23M
Reddito:
$160.43M
Utile/perdita netta:
$-227.64M
Rapporto P/E:
-0.0704
EPS:
-68.77
Flusso di cassa netto:
$-170.79M
1 W Prestazione:
-3.20%
1M Prestazione:
+41.11%
6M Prestazione:
+76.64%
1 anno Prestazione:
-71.00%
Intervallo 1D:
Value
$4.34
$5.05
Intervallo di 1 settimana:
Value
$4.34
$5.22
Portata 52W:
Value
$1.38
$18.74

Agenus Inc Stock (AGEN) Company Profile

Name
Nome
Agenus Inc
Name
Telefono
781-674-4410
Name
Indirizzo
3 FORBES ROAD, LEXINGTON, MA
Name
Dipendente
316
Name
Cinguettio
@Agenus_Bio
Name
Prossima data di guadagno
2024-12-05
Name
Ultimi documenti SEC
Name
AGEN's Discussions on Twitter

Confronta AGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AGEN
Agenus Inc
4.84 147.23M 160.43M -227.64M -170.79M -68.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Agenus Inc Stock (AGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-04 Aggiornamento H.C. Wainwright Neutral → Buy
2024-07-19 Downgrade Robert W. Baird Outperform → Neutral
2024-07-18 Downgrade H.C. Wainwright Buy → Neutral
2024-07-18 Downgrade William Blair Outperform → Mkt Perform
2023-06-06 Iniziato Robert W. Baird Outperform
2023-02-28 Ripresa H.C. Wainwright Buy
2022-09-28 Iniziato SMBC Nikko Outperform
2021-12-16 Iniziato H.C. Wainwright Buy
2019-11-19 Ripresa B. Riley FBR Buy
2019-04-22 Iniziato B. Riley FBR Buy
2016-10-28 Downgrade H.C. Wainwright Buy → Neutral
2016-10-27 Reiterato Maxim Group Buy
2016-03-11 Aggiornamento Maxim Group Hold → Buy
2015-12-16 Iniziato Jefferies Buy
2015-10-27 Downgrade Maxim Group Buy → Hold
2015-07-27 Reiterato MLV & Co Buy
2015-06-11 Iniziato Oppenheimer Outperform
2015-01-12 Reiterato Maxim Group Buy
2015-01-09 Reiterato MLV & Co Buy
2015-01-09 Reiterato Maxim Group Buy
2014-12-19 Reiterato Maxim Group Buy
2014-05-08 Reiterato Maxim Group Buy
2014-03-14 Reiterato MLV & Co Buy
2013-10-08 Reiterato Maxim Group Buy
2012-01-05 Iniziato William Blair Outperform
2011-12-01 Iniziato Global Hunter Securities Buy
Mostra tutto

Agenus Inc Borsa (AGEN) Ultime notizie

pulisher
Jun 18, 2025

# Agenus and Noetik partner to develop AI-powered cancer treatment biomarkers - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus Partners With Noetik to Advance Biomarker Discovery for Lead Cancer Immunotherapy Combo - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus (AGEN) and Noetik Collaborate to Enhance Cancer Treatment - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus, Noetik Enter Research Collaboration - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology | AGEN Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

AI Breakthrough: Agenus and Noetik Join Forces to Revolutionize Cancer Patient Selection Using Virtual Cell Models - Stock Titan

Jun 17, 2025
pulisher
Jun 15, 2025

10 Most Undervalued Stocks to Buy for Under $5 - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Is Zydus’s Agenus Deal Opportunistic Or Strategic? - insights.citeline.com

Jun 12, 2025
pulisher
Jun 11, 2025

Agenus Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire

Jun 11, 2025
pulisher
Jun 10, 2025

H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus Announces Virtual Annual Shareholders Meeting - New Castle News

Jun 10, 2025
pulisher
Jun 10, 2025

How to Join Agenus 2025 Virtual Shareholders Meeting: Complete Registration Guide - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN

Jun 10, 2025
pulisher
Jun 09, 2025

Agenus Inc. (NASDAQ:AGEN) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN

Jun 07, 2025
pulisher
Jun 07, 2025

Research Analysts Issue Forecasts for Agenus FY2027 Earnings - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

HC Wainwright Forecasts Agenus’ Q3 Earnings (NASDAQ:AGEN) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million - Medical Dialogues

Jun 06, 2025
pulisher
Jun 05, 2025

Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus (NASDAQ:AGEN) Upgraded to “Buy” at HC Wainwright - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. Baird - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL - Medical Dialogues

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - 뉴스와이어

Jun 05, 2025
pulisher
Jun 04, 2025

Agenus Announces Strategic Collaboration with Zydus - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus IncSigns Partnership Agreements With Zydus Lifesciences - MarketScreener

Jun 04, 2025
pulisher
Jun 04, 2025

Analyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangAgenus (NASDAQ:AGEN) - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus Shares Rise After Upgrade From HC Wainwright - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

H.C. Wainwright upgrades Agenus stock on strategic collaboration - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

H.C. Wainwright upgrades Agenus stock on strategic collaboration By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Mai - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Maintained | AGEN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Upgraded to 'Buy' by HC Wainwright & Co. | AGEN St - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

HC Wainwright & Co. Upgrades Agenus (AGEN) - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Stock Price Target Increased by Baird | AGEN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus and Zydus sign agreements for botensilimab and balstilimab - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus gets rights for next gen I-O platforms from Agenus - The Pharma Letter

Jun 04, 2025
pulisher
Jun 04, 2025

HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | A - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | AGEN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus signs deal with Agenus for next-gen cancer immunotherapies - Healthcare Radius

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to enter global biologics CDMO business to accelerate development of innovative therapies - Pharmabiz.com

Jun 04, 2025
pulisher
Jun 04, 2025

Jane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilitiesto accelerate development of innovative therapies - APN News

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to acquire Agenus’ US manufacturing facilities, forays into global biologics CDMO business - Indian Pharma Post

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - StreetInsider

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus inks $141M deal with Zydus for cancer drugs, facilities By Investing.com - Investing.com South Africa

Jun 04, 2025

Agenus Inc Azioni (AGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):